Effects of cinitapride on gastric ulceration and secretion in rats

Inflammation Research

Volumn 47, Issue 3, 1998, Pages 131-136

  Alarcon De La Lastra C ^a   La Casa, C ^a   Martin, M J ^a   Motilva, V ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

5 Hydroxytryptamine; Cinitapride; Gastric ulceration; Neutrophils; Oxygen free radicals

Indexed keywords

CINITAPRIDE; GLUTATHIONE PEROXIDASE; INTESTINE CONTRACTION STIMULATING AGENT; MYELOPEROXIDASE; SEROTONIN; SEROTONIN 1 RECEPTOR; SEROTONIN 2 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; STOMACH HEMORRHAGE; STOMACH PH; STOMACH SECRETION; STOMACH ULCER;

ANIMALS; ANTI-ULCER AGENTS; BENZAMIDES; CAPILLARY PERMEABILITY; ETHANOL; GASTRIC ACID; GASTRIC MUCOSA; GASTROINTESTINAL MOTILITY; GLUTATHIONE PEROXIDASE; INJECTIONS, INTRAPERITONEAL; MALE; PEROXIDASE; PYLORUS; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; STOMACH ULCER;

EID: 0031944056     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050301     Document Type: Article

References (33)

1. Read NW, Gwee KA. The importance of 5-hydroxytryptamine receptors in the gut. Pharmacol Ther 1994;62:159-73.
2. Cho CH, Ogle OW. The inhibitory action of 5-hydroxytryptamine on gastric secretory function in rats. Br J Pharmacol 1986;87:371-7.
3. Wong SH, Cho CH, Ogle CW. The role of serotonin in ethanol-induced gastric glandular damage in rats. Digestion 1990;45:52-60.
4. 4 receptor: A place in the sun. Trends Pharmacol Sci 1992;13:141-5.
5. Kerrigan DD, Taylor ME, Read NW, Johnson AD. Acid motility and ulcers: A comparison of cisapride and placebo in the prevention of duodenal ulcer relapse. Gut 1993;34:1042-6.
6. Simon B, Nonnenmacher A, Dammann HG, Muller P. Gastroprokinetika zur Behandlung des Magenulkus. Eine direkte Vergleichsstudie Cisapride versus Ranitidine. Z Gastroenterol 1990;28(Suppl 1):85-8.
7. Testoni PA, Bagnolo F, Masci E, Toti G, Spinelli A. Efficacy of cisapride in gastric ulcer: Results of a double-blind randomized trial versus ranitidine. J Clin Gastroenterol 1993;17:5-9.
8. López A, Motilva V, Alarcón de la Lastra C, Martín MJ, La Casa C. The role of gastric mucosal sulphydryls in the ulcer-protecting effects of cisapride. J Pharm Pharmacol 1996;48:37-40.
9. Alarcón de la Lastra C, Martín MJ, La Casa C, López A, Motilva V. Effects of cisapride on ulcer formation and gastric secretion in rats: comparison with ranitidine and omeprazole. Gen Pharmacol 1996; 27:1415-20.
10. Motilva V, López A, Martín MJ, La Casa C, Alarcón de la Lastra C. Cytoprotective activity of cisapride on experimental gastric mucosal lesions induced by ethanol. Role of endogenous prostaglandins. Prostaglandins 1996;52:63-74.
11. Harris A. Treatment of Helicobacter pylori. Drugs of Today 1997;33:59-66.
12. Labenz J, Idstrom JP, Tillenburg B, Peitz U, Adamek RJ, Börsch G. One-week low-dose triple therapy for Helicobacter pylori is sufficient for relief from symptons and healing of duodenal ulcers. Aliment Pharmacol Ther 1997;11:89-93.
13. Fernández AG, Roberts DJ. Cinitapride hydrogen tartrate. Drugs 1991;16:885-92.
14. Gallego Santos J, Fombuena Filpo J, Martinez López J. Efficacy and tolerability of cinitapride in gastrointestinal transit disturbances. Rev Med Univ Navarra 1991;36:8-12
15. Surós A, Adell F, De Novoa V, Castellarnau J, Diosdado D, Carrasquer J, et al. Cinitapride in the treatment of gastroesophageal reflux. Rev Med Univ Navarra 1992;37:18-23.
16. Alarcón de la Lastra C, López A, Martín MJ, La Casa M, Motilva V. Cinitapride protects against ethanol-induced-gastric mucosal injury in rats: Role of 5-hydroxytryptamine, prostaglandins and sulfhydryl compounds. Pharmacology 1997;54:193-202.
17. Whittle JR. Neuronal and endothelium-derived mediators in the modulation of the gastric microcirculation: Integrity in the balance. Br J Pharmacol 1993;110:3-17.
18. Kvietys PR, Twohig B, Danzell J, Specian RD. Ethanol-induced injury to the rat gastric mucosa. Role of neutrophils and xanthine oxidase-derived radicals. Gastroenterology 1990;98:909-20.
19. Takeuchi K, Megumu O, Hiromichi N, Okabe S. Role of sulphydryls in mucosal injury caused by ethanol. Relation to microvascular permeability, gastric motility and cytoprotection. J Pharm Exp Ther 1988;248:836-9.
20. Grisham MB, Beniot JN, Granger DN. Assessment of leukocyte involvement during ischemia and reperfusion on the intestine. In: Packer L, Glazer AN, editors. Methods in enzymology. Oxygen radicals in biological systems. San Diego: Academic Press, 1990: 729-41.
21. Yoshikawa T, Naito Y, Tomii T, Kaneko T, Iinuma S, Ichikawa H, et al. Role of active oxygen, lipid peroxidation and antioxidants in the pathogenesis of gastric mucosal injury induced by indomethacin in rats. Gut 1993;34:732-7.
22. Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
23. Shay H, Komarov SA, Fels SS, Meranze D, Grunstein M, Simpler H. A simple method for the uniform production of gastric ulceration in the rat. Gastroenterology 1945;5;43-61.
24. Prino G, Paglialunga S, Nardi G, Lietti A. Inhibition of experimentally induced gastric ulcers in the rat by a new sulfated glycopeptide. Eur J Pharm 1971;15;119-26.
25. Wallace IL, McKnight W, Miyasaka M, Tamatani T, Paulson J, Anderson DC. Role of endothelial adhesion molecules in NSAID-induced gastric mucosal injury. Am J Physiol 1993;265:G993-8.
26. Anthony A, Sim AP, Pounder RE, Wakefield A J. Gastric mucosal contraction and vascular injury induced by indomethacin-preceded neutrophil infiltration in the rat. Gut 1996;39:363-8.
27. Zimmerman BJ, Granger DN. Oxygen free radicals and the gastrointestinal tract: Role of ischemia-reperfusion injury. Hepatogastroenterology 1994;41:337-42.
28. Cho CH, Mei QB, Sheung KK. The intraperitoneal effects of 5-hydroxytryptamine on haemodynamics gastric mucosal blood flow and platelet aggregation. Eur J Pharmacol 1994:25:9-15.
29. Ogle CW, Hui BS, Li KM. 5-Hydroxytryptamine 3-receptor blockade protects against gastric mucosal damage in rats. Aca Physiol Hung 1992;80:181-8.
30. 2 blockade protects against ischaemia-reperfusion injury in rats. Role of oxygen free radicals and lipid peroxidation. J Pharm Sci 1996;2:491-3.
31. 3 antagonist, on gastric emptying in the guinea pig. Br J Pharmacol 1987;91:263-4.
32. Llupiá J, Bou J, Fernandez AG, Berga P. Mediation of the serotonergic system in the pharmacological activity of cinitapride. Rev Farmacol Clin Exp 1989;6:255.
33. Hyrdel R, Koklesová, Demeter M, Boziková J. The positive role of cisapride in the treatment of patients with resistant peptic ulcers. Gut 1997; 41(Suppl 3):A155.